NuVasive Q3 Income at $7M, Up Nearly 250% From Last Year

NuVasive reported its consolidated net income in the third quarter of $7.3 million, up nearly 250 percent compared to the same period last year.

Advertisement

The company reported $169 million in total third quarter revenue, up 14 percent from the same period last year. Spine revenue also jumped this past quarter, up 16 percent to $131 million. Biologics and monitoring services experienced modest increases.

More Articles on Devices:
Device Companies — 7 Key Notes — Zimmer, Boston Scientific & More
Baxano Surgical Granted Patent for Visual Approach of Lateral Access Fusion System
Orthozon Technologies’ Lumiere Retractor System Recognized as Top Device for Spine

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.